CSRF in Bdtask G-Prescription Gynaecology \& Obs Consultation

CVE-2024-2277

A vulnerability was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0 and classified as problematic. Affected by this issue is some unknown functionality of the file /Setting/change_password_save of the component Password Reset Handler. The manipulation leads to cross-site request forgery. The attack may be launched remotely. The exploit has been disclosed to the public and may be used. VDB-256046 is the identifier assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Vulnerability class: CSRF (Cross-Site Request Forgery)

Published · last modified .

CVSS v3 metric

CVSS v3 base score 4.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N.

EPSS exploit prediction

EPSS: 0.003 (23.7th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 24th percentile — 23.7% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2024-2277: held from 0.003 to 0.003.

EPSS over last 30 days · oldest: 0.003 · newest: 0.003 · change: 0.000

Affected products

Weakness classification (CWE)

Public proof-of-concept exploits

References

Frequently asked questions

What is CVE-2024-2277?
CVE-2024-2277 is a medium-severity vulnerability in Bdtask G-Prescription Gynaecology \& Obs Consultation, classified under Cross-Site Request Forgery (CSRF). CVSS score: 4.3/10. Published 2024-03-08.
How severe is CVE-2024-2277?
Medium severity. CVSS v3 base score is 4.3 out of 10.
Is CVE-2024-2277 known to be exploited?
1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.